Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$233K Buy
878
+3
+0.3% +$808 0.02% 311
2021
Q3
$253K Buy
+875
New +$224K 0.02% 222
2021
Q1
Sell
-1,269
Closed -$243K 438
2020
Q4
$243K Buy
+1,269
New +$231K 0.02% 238

Other funds holding RGEN

6 Meridian's RGEN Position: Q4 2021 in Review

6 Meridian increased its Repligen (RGEN) stake by 0.34% in Q4 2021, buying an estimated $808 and bringing the position to 878 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #311.

6 Meridian first reported a position in RGEN in Q4 2020 and has held it in 3 quarters since. The position peaked at $253K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • 6 Meridian held 878 shares of Repligen worth $233K as of Q4 2021.
  • 6 Meridian bought 3 Repligen shares in Q4 2021, an estimated $808.
  • Repligen made up 0.02% of 6 Meridian's portfolio in Q4 2021, its #311 holding.
  • 6 Meridian first reported a position in Repligen in Q4 2020 and has held it in 3 quarters since.
  • 6 Meridian's Repligen position peaked at $253K in Q3 2021.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.